SC
IDXX icon

Steph & Co’s Idexx Laboratories IDXX Stock Holding History

Steph & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-365
Closed -$153K – 306
2025
Q1 		$153K Buy
365
+20
+6% +$8.68K 0.06% 125
2024
Q4 		$143K Buy
345
+21
+6% +$9.21K 0.05% 135
2024
Q3 		$164K Sell
324
-12
-4% -$5.83K 0.05% 133
2024
Q2 		$164K Buy
336
+3
+0.9% +$1.51K 0.06% 125
2024
Q1 		$180K Buy
333
+38
+13% +$20.8K 0.06% 120
2023
Q4 		$164K Sell
295
-20
-6% -$9.39K 0.08% 113
2023
Q3 		$138K Buy
315
+14
+5% +$6.98K 0.08% 129
2023
Q2 		$151K Buy
301
+14
+5% +$6.71K 0.08% 122
2023
Q1 		$144K Buy
+287
New +$137K 0.09% 119

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Steph & Co's IDXX Position: Q2 2025 in Review

Steph & Co sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 365 shares — an estimated $153K sold.

Steph & Co first reported a position in IDXX in Q1 2023 and held it in 9 quarters. The position peaked at $180K in Q1 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Steph & Co reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Steph & Co sold 365 Idexx Laboratories shares in Q2 2025, an estimated $153K.
  • Steph & Co first reported a position in Idexx Laboratories in Q1 2023 and held it in 9 quarters.
  • Steph & Co's Idexx Laboratories position peaked at $180K in Q1 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Steph & Co's 13F filing for Q2 2025, filed 16 Jul 2025.